MUMBAI, 22 September 2026 — Mastercard Asia/Pacific may sell up to 49.7 million Pine Labs shares through a proposed secondary block transaction with a ₹179.50 floor price, according to deal terms independently described by multiple financial publications.
Proposed transaction terms
| Potential seller | Mastercard Asia/Pacific Pte. Ltd. |
|---|---|
| Maximum shares | about 49.7 million |
| Approximate stake | 4.3% |
| Floor price | ₹179.50 per share |
| Maximum indicated value | about ₹892–₹892.5 crore |
| Structure | Secondary sale; not new Pine Labs capital |
This is not yet reported as a completed trade
The cited term sheets scheduled the transaction for September 22, but a scheduled block sale can be resized, repriced within applicable rules or not completed. At CapKet’s publication cut-off, the article relies on reported deal terms rather than a final exchange record. The headline and body therefore use “proposed” and “may sell” rather than declaring an exit complete.
Relationship to the disclosed holding
Reports citing exchange data place Mastercard Asia/Pacific’s June 30 holding at 49,724,182 shares, or 4.31% of Pine Labs. The offered amount is broadly equal to that disclosed position. Final ownership can be established only after executed trade data and subsequent shareholding disclosures are available.
Why the floor-price discount matters
The ₹179.50 floor was reported at about a 7.3% discount to Pine Labs’ prior NSE close. A floor is the minimum level specified for the marketed transaction; it is not a guarantee that public-market investors can trade the same quantity or obtain the same execution. A transaction of this size can also affect short-term liquidity and price discovery.
No proceeds to Pine Labs
Because the proposed transaction is a secondary sale by an existing shareholder, its proceeds would accrue to the seller rather than Pine Labs. It should not be described as new fundraising by the company. The relevant follow-up evidence is the official exchange block or bulk-deal disclosure, followed by any company or shareholder filing.
Source and risk notice: The proposed terms come from named financial reports and are cross-checked against official company and exchange disclosure channels. CapKet has not copied another publication’s wording and will not mark the transaction complete without official evidence. This is not investment advice.